LTB4-induced anti-apoptosis and infiltration of neutrophils in rheumatoid arthritis

被引:1
作者
Li, K. -X. [1 ]
Zheng, L. -X. [1 ]
Guo, H. -Q. [1 ]
Hong, F. -F. [2 ]
Yang, S. -L. [1 ]
机构
[1] Nanchang Univ, Coll Med, Dept Physiol, Nanchang 330006, Jiangxi, Peoples R China
[2] Nanchang Univ, Dept Expt Teaching Ctr, Nanchang 330031, Jiangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
LTB4; neutrophil; anti-apoptosis; infiltration; rheumatoid arthritis; COLLAGEN-INDUCED ARTHRITIS; LEUKOTRIENE B-4 RECEPTORS; SIGNAL-REGULATED KINASE; KAPPA-B PATHWAY; PHOSPHATIDYLINOSITOL; 3-KINASE; TNF-ALPHA; PHOSPHOINOSITIDE; MONOCLONAL-ANTIBODY; MCL-1; EXPRESSION; CELL-MIGRATION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rheumatoid arthritis (RA) is the most common autoimmune disease, resulting in synovitis, joint pain and stiffness, even deformity and disability. The interactions between leukotriene B4 (LTB4) and neutrophils in RA progression have not been elucidated in detail. Our review focuses on the correlation of LTB4 and neutrophils in the development of RA especially in terms of infiltration and delayed life span of neutrophils. In this article, the roles of LTB4 in the anti-apoptosis of neutrophils will be detailed, which is achieved by suppressed pro-apoptotic Bax and up-regulated anti-apoptotic Mcl-1, and several key molecules, as well as signalling pathways and factors relevant to the enhancement of LTB4 production and functions. The mechanisms of LTB4-induced anti-apoptosis and infiltration of neutrophils provide more potential targets in the treatment of RA and recent therapeutic strategies are also discussed.
引用
收藏
页码:543 / 551
页数:9
相关论文
共 106 条
[1]   LTB4 Is a Signal-Relay Molecule during Neutrophil Chemotaxis [J].
Afonso, Philippe V. ;
Janka-Junttila, Mirkka ;
Lee, Young Jong ;
McCann, Colin P. ;
Oliver, Charlotte M. ;
Aamer, Khaled A. ;
Losert, Wolfgang ;
Cicerone, Marcus T. ;
Parent, Carole A. .
DEVELOPMENTAL CELL, 2012, 22 (05) :1079-1091
[2]   Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy [J].
Alam, Javaid ;
Jantan, Ibrahim ;
Bukhari, Syed Nasir Abbas .
BIOMEDICINE & PHARMACOTHERAPY, 2017, 92 :615-633
[3]   Inhibition of leukotriene B4-induced CD11B/CD18 (Mac-1) expression by BIIL 284, a new long acting LTB4 receptor antagonist, in patients with rheumatoid arthritis [J].
Alten, R ;
Gromnica-Ihle, E ;
Pohl, C ;
Emmerich, J ;
Steffgen, J ;
Roscher, R ;
Sigmund, R ;
Schmolke, B ;
Steinmann, G .
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (02) :170-176
[4]   NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B4 in a murine model of gout [J].
Amaral, Flavio A. ;
Costa, Vivian V. ;
Tavares, Livia D. ;
Sachs, Daniela ;
Coelho, Fernanda M. ;
Fagundes, Caio T. ;
Soriani, Frederico M. ;
Silveira, Tatiana N. ;
Cunha, Larissa D. ;
Zamboni, Dario S. ;
Quesniaux, Valerie ;
Peres, Raphael S. ;
Cunha, Thiago M. ;
Cunha, Fernando Q. ;
Ryffel, Bernhard ;
Souza, Daniele G. ;
Teixeira, Mauro M. .
ARTHRITIS AND RHEUMATISM, 2012, 64 (02) :474-484
[5]  
[Anonymous], 2016, Adv. Mater. Sci. Eng
[6]   Heme inhibits human neutrophil apoptosis:: Involvement of phosphoinositide 3-kinase, MAPK, and NF-κB [J].
Arruda, MA ;
Rossi, AG ;
de Freitas, MS ;
Barja-Fidalgo, C ;
Graça-Souza, AV .
JOURNAL OF IMMUNOLOGY, 2004, 173 (03) :2023-2030
[7]   NADPH oxidase-derived ROS: Key modulators of heme-induced mitochondrial stability in human neutrophils [J].
Arruda, Maria Augusta ;
Barcellos-de-Souza, Pedro ;
Franco Sampaio, Andre Luiz ;
Rossi, Adriano G. ;
Graca-Souza, Aurelio V. ;
Barja-Fidalgo, Christina .
EXPERIMENTAL CELL RESEARCH, 2006, 312 (19) :3939-3948
[8]   Leukotriene B4 inhibits neutrophil apoptosis via NADPH oxidase activity: Redox control of NF-κB pathway and mitochondrial stability [J].
Barcellos-de-Souza, Pedro ;
Canetti, Claudio ;
Barja-Fidalgo, Christina ;
Arruda, Maria Augusta .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2012, 1823 (10) :1990-1997
[9]   Inhibition of neutrophil infiltration by a malleable protein matrix of lactic acid bacteria-fermented whey proteins in vivo [J].
Beaulieu, J. ;
Girard, D. ;
Dupont, C. ;
Lemieux, P. .
INFLAMMATION RESEARCH, 2009, 58 (03) :133-138
[10]   Recent advances in clinical development of leukotriene B4 pathway drugs [J].
Bhatt, L. ;
Roinestad, K. ;
Van, T. ;
Springman, E. B. .
SEMINARS IN IMMUNOLOGY, 2017, 33 (0C) :65-73